In an article featured on MassDevice, a group of large-cap Med-tech CEOs in a panel discussion at the recent OneMed conference in San Francisco indicated that emerging markets are too complex for smaller firms to navigate. Given the slowing growth of the U.S and European markets, emerging markets are very tempting. However, entry into these markets can be very challenging.